{
    "clinical_study": {
        "@rank": "31953", 
        "arm_group": [
            {
                "arm_group_label": "Amoxicillin", 
                "arm_group_type": "Experimental", 
                "description": "The patient will be received amoxicillin 500 mg  2 capsules orally bid pc for 5 days"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The patient will be received placebo  2 capsules orally bid pc for 5 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine amoxicillin is effective in the prevention of\n      wound infection in normal labor."
        }, 
        "brief_title": "Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Perineal Wound Infection", 
        "condition_browse": {
            "mesh_term": "Wound Infection"
        }, 
        "detailed_description": {
            "textblock": "When the pregnant women is admitted due to  first stage of labor , the investigator will\n      inform the patients. If the patients give consent, the patient's data will be collect in\n      case record form. the patients will be swab at posterior fornix and around anus to collect\n      specimen and send to microbiology lab before per vaginal examination. After the patients\n      finish in labor, perineal wound will be swab to collect specimen and send to microbiology\n      lab. Then the patients are randomized in two group, the first one will receive amoxicillin\n      and the second one will receive placebo. During admission the patients will be exam by\n      investigator every day. After the patients are discharge, the follow up will be appoint on 6\n      weeks later. The infant will be swab at rectum to collect specimen and send to microbiology\n      lab when the patient's discharge day. Every specimen will be culture for bacteria and\n      perform antimicrobial susceptibility test for amoxicillin."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Term pregnancy\n\n          -  Normal labor\n\n        Exclusion Criteria:\n\n          -  Penicillin allergy\n\n          -  Previous history antibiotic using within 2 weeks\n\n          -  Patients cannot take oral medication\n\n          -  Patients have underlying disease eg. diabetes mellitus, hypertension, HIV infection\n\n          -  Premature rupture of membranes"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02131818", 
            "org_study_id": "SI-OBG-CEU-01-2014"
        }, 
        "intervention": [
            {
                "arm_group_label": "Amoxicillin", 
                "description": "The patient will be received amoxicillin 500 mg  2 capsules orally bid pc for 5 days", 
                "intervention_name": "Amoxicillin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Drug A", 
                    "Drug B"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "The patient will be received placebo  2 capsules orally bid pc for 5 days", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Drug A", 
                    "Drug B"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amoxicillin", 
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "amoxicillin", 
            "postpartum infections", 
            "puerperal infection"
        ], 
        "lastchanged_date": "May 4, 2014", 
        "location": {
            "contact": {
                "email": "vitaya.tit@mahidol.ac.th", 
                "last_name": "Vitaya Titapant, MD", 
                "phone": "+66816851907"
            }, 
            "contact_backup": {
                "email": "sipr@mahidol.ac.th", 
                "last_name": "Pornpimol Ruangvutilert, MD", 
                "phone": "+66819170809"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10700"
                }, 
                "name": "Faculty of Medicine Siriraj Hoapital Mahidol University"
            }, 
            "investigator": {
                "last_name": "Vitaya Titapant, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term", 
        "overall_contact": {
            "email": "vitaya.tit@mahidol.ac.th", 
            "last_name": "Vitaya Titapant, MD", 
            "phone": "+66816851907"
        }, 
        "overall_contact_backup": {
            "email": "sipr@mahidol.ac.th", 
            "last_name": "Pornpimol Ruangvutilert, MD", 
            "phone": "+66819170809"
        }, 
        "overall_official": {
            "affiliation": "Department of Obstetrics & Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand", 
            "last_name": "Vitaya Titapant, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Thailand: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Follow up perineal wound every day during admission and follow up 6 weeks after discharge", 
            "measure": "Incidence of perineal wound infection", 
            "safety_issue": "Yes", 
            "time_frame": "within 6 weeks after normal labor"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02131818"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Mahidol University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mahidol University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}